| PATENT REGISTER | |||||||||||||||||||||||||||||||
| A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2018/010 | |||||||||||||||||||||||||||||||
| Status | Expired | Patent No. | 1827461 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application No. | 05823474.1 | Date of Filing | 20/12/2005 | ||||||||||||||||||||||||||||
| Date Grant Published | 29/02/2012 | Application Published | 05/09/2007 | ||||||||||||||||||||||||||||
| Title of Invention | CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS | ||||||||||||||||||||||||||||||
| Priority |
|
||||||||||||||||||||||||||||||
| Inventors |
DE LUCA, Giampiero YTHIER, Arnaud MUNAFO, Alain LOPEZ-BRESNAHAN, Maria |
||||||||||||||||||||||||||||||
| Current Proprietor |
Merck Serono S.A. Rue de l’Ouriette 151 Zone industrielle de l’Ouriettaz CH-1170 Aubonne FRANCE |
||||||||||||||||||||||||||||||
| Address for service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||||||||||||||||||||||||||||||
| Renewal Fees |
|
||||||||||||||||||||||||||||||
| Publication Language | English | ||||||||||||||||||||||||||||||
| Translation Received Date | |||||||||||||||||||||||||||||||
| 05/03/2012 | Divisional Application number: 10182632.9 Publication number: 2275110 Date of receipt: 29/09/2010 | ||||||||||||||||||||||||||||||
| 05/03/2012 | Divisional Application number: 10182676.6 Publication number: 2263678 Date of receipt: 29/09/2010 | ||||||||||||||||||||||||||||||
| 06/03/2012 | Address for Service recorded as FRKelly, 27 Clyde Road, Ballsbridge, Dublin 4, Ireland received on 01/03/2012. | ||||||||||||||||||||||||||||||
| 14/02/2018 | Request for grant a Supplementary Protection Certificate, citing Patent number 1827461 as the relevant basic patent, in respect of the product Cladribine filed on 09/02/2018. Reference number of request is 2018/010. | ||||||||||||||||||||||||||||||
| 08/09/2025 | Request for grant of Supplementary Protection Certification No. 2018/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009 | ||||||||||||||||||||||||||||||
| 05/01/2026 | Patent expired on 19/12/2025. | ||||||||||||||||||||||||||||||
| 27/05/2026 | Change of address of proprietor from Merck Serono SA, Centre Industriel, 1267 Coinsins, Vaud, Switzerland to Merck Serono S.A., Rue de l’Ouriette 151, Zone industrielle de l’Ouriettaz, CH-1170 Aubonne, France recorded on 11/05/2026. | ||||||||||||||||||||||||||||||
